D-0545-2018 Class II Terminated

Recalled by ALLERGAN — Madison, NJ

FDA drug recall D-0545-2018 was initiated by ALLERGAN on Dec 13, 2017 and is designated Class II. Reason for recall: Failed Stability Specifications: Product stability testing results did not meet specifications for iron content. The recall status is terminated (terminated Apr 8, 2020). Affected quantity: 163,694 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 7, 2018
Initiation Date
Dec 13, 2017
Termination Date
Apr 8, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
163,694 cartons

Product description

INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 ml (50 mg/mL), Rx Only, packaged in a) single dose vials, (NDC 52544-931-07), b) carton of 10 x 2 ml Single Dose Vials (NDC 52544-931-02) Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, Manufactured by: Patheon Italia S.p.A. Ferentino, Italy 03013.

Reason for recall

Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.

Distribution pattern

Product was distributed nationwide in the USA.

Code information

Lot# 15W05A, Exp.FEB-2018; 16W02A, Exp. DEC 2018; 16W05A, Exp. JAN-2019; 16W13A, Exp. APR-2019; 16W15A, 16W16A, 16W17A, Exp. MAY 2019; 16W18A, Exp. JUN 2019; 16W20A, 16W22A, Exp. SEP 2019; 17W01A, 17W02A, Exp. DEC-2019; 17W04A, 17W05A, Exp. JAN 2020; 17W09A, Exp. MAR-2020; 17W11A, 17W13A, Exp. MAY 2020; 17W14A, 17W15A, Exp. JUN 2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0545-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0545-2018. Report a data issue: hello@regdatalab.com.